← Back to Search

Electromagnetic Field Treatment

Electromagnetic Field Treatment for Stroke (BQ5 Trial)

N/A
Waitlist Available
Led By Jeffrey L Saver, MD
Research Sponsored by BrainQ Technologies Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with an ischemic stroke, confirmed by CT or MRI imaging.
Able to sit with the investigational device for 40 consecutive minutes.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline (4-21 days post stroke) to 90 days post stroke (will be assessed at 90 day fu visit)
Awards & highlights

BQ5 Trial Summary

This trial is a multicenter study that will test whether the BQ 2.0, a wearable medical device that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields, can reduce disability in adult patients with subacute ischemic stroke, with a moderate to severe disability which includes an upper extremity motor impairment.

Who is the study for?
Adults aged 22-85 with recent ischemic stroke, moderate to severe disability including arm impairment, and able to follow simple commands. Must not be pregnant or at risk of pregnancy without contraception. Requires a caregiver for support during therapy sessions.Check my eligibility
What is being tested?
The BQ 2.0 device is being tested for its ability to aid recovery in stroke patients by delivering low-intensity electromagnetic fields during physical and occupational therapy over a period of 9 weeks.See study design
What are the potential side effects?
Potential side effects are not specified but may include discomfort from wearing the device or skin irritation due to adhesive materials used.

BQ5 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a stroke confirmed by a scan.
Select...
I can sit still for 40 minutes with a medical device.
Select...
I can understand and follow simple instructions.
Select...
I am between 22 and 85 years old.
Select...
I need some help with my daily activities due to my health condition.
Select...
I have had a stroke confirmed by a scan.
Select...
Before my stroke, I had no or minimal disability.
Select...
I need some help with my daily activities due to my condition.
Select...
I am between 22 and 85 years old.
Select...
I was fully independent before my stroke.

BQ5 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline (4-21 days post stroke) to 90 days post stroke (will be assessed on 90 day fu visit )
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline (4-21 days post stroke) to 90 days post stroke (will be assessed on 90 day fu visit ) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Modified Rankin Scale
Secondary outcome measures
Change from Baseline in 10 Meter Walk Test (gait speed)
Change from Baseline in Box and Block Test (fine hand function)
Change from Baseline in Fugl-Meyer Assessment for Upper Extremity (upper limb function)
+3 more
Other outcome measures
Change from Baseline in 5-level EQ-5D (health-related quality of life) at 180 days post-stroke.
Change from Baseline in Modified Rankin Scale (global disability)
Change from Baseline in Stroke Impact Scale Hand Domain (patient-reported hand function)
+6 more

BQ5 Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: BQ 2.0 active stimulation groupActive Control1 Intervention
45 sessions over a period of 9 weeks (5 treatments per week) of active study intervention with BQ 2.0 including a standardized, pre-defined and evidence-based physical and occupational therapy regimen concurrent with the study intervention.
Group II: BQ 2.0 sham stimulation groupPlacebo Group1 Intervention
45 sessions over a period of 9 weeks (5 treatments per week) of sham study intervention with BQ 2.0 including a standardized, pre-defined and evidence-based physical and occupational therapy regimen concurrent with the study intervention.

Find a Location

Who is running the clinical trial?

BrainQ Technologies Ltd.Lead Sponsor
2 Previous Clinical Trials
36 Total Patients Enrolled
Jeffrey L Saver, MDPrincipal InvestigatorLead Coordinating PI
2 Previous Clinical Trials
884 Total Patients Enrolled
1 Trials studying Ischemic Stroke
498 Patients Enrolled for Ischemic Stroke
Pamela W Duncan, PhDPrincipal InvestigatorLead Coordinating PI

Media Library

BQ 2.0 (Electromagnetic Field Treatment) Clinical Trial Eligibility Overview. Trial Name: NCT05044507 — N/A
Ischemic Stroke Research Study Groups: BQ 2.0 sham stimulation group, BQ 2.0 active stimulation group
Ischemic Stroke Clinical Trial 2023: BQ 2.0 Highlights & Side Effects. Trial Name: NCT05044507 — N/A
BQ 2.0 (Electromagnetic Field Treatment) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05044507 — N/A
Ischemic Stroke Patient Testimony for trial: Trial Name: NCT05044507 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What results are researchers expecting to arise from this trial?

"The primary outcome of this study, spanning from 4-10 days post stroke to 90 days after the incident, is an alteration in Modified Rankin Score. As secondary goals, researchers seek a decrease in upper limb impairment (assessed by EQ-5D-5L), improvement of fine hand function (measured with Box and Block Test) as well as a quicker gait speed (as determined by 10 Meter Walk Test)."

Answered by AI

What criteria must be met to qualify for enrollment in this clinical trial?

"This investigation is accepting 78 patients with wake-up stroke between the ages of 22 and 80. To qualify, participants must have a Modified Rankin Scale (mRS) score of 3 or 4, a pre-stroke mRS score of 0 or 1, an Fugl Meyer Assessment - Upper Extremity (FMA-UE) score within 10 to 45 range , be able to follow a three step command such as "take the paper, fold it in half and return it to me", agree to partake in occupational/physical therapy activities during treatment sessions via video call alongside their relative or caregiver who are available for assistance throughout this trial"

Answered by AI

Does this research encompass the elderly demographic?

"As set forth in the participation requirements, individuals must be between 22 and 80 years old to qualify for this medical study."

Answered by AI

How many participants are currently enrolled in this clinical experiment?

"To complete the trial, 78 qualified participants need to register. Those eligible can join in from either Moss Rehabilitation Research Institute (Elkins Park, Pennsylvania) or Ronald Reagan UCLA Medical Center & California Rehabilitation Institute (Los Angeles, California)."

Answered by AI

Is there room to join this experiment?

"This experiment is actively seeking participants, as indicated on clinicaltrials.gov. It was originally posted on December 4th 2021 and last edited on August 10th 2022."

Answered by AI

How many medical centers are currently involved in this clinical trial?

"The list of available clinical trial sites includes Moss Rehabilitation Research Institute in Elkins Park, Ronald Reagan UCLA Medical Center & California Rehabilitation Institute in Los Angeles, and Baylor Scott & White Institute for Rehabilitation in Dallas. 11 other medical facilities are also participating."

Answered by AI

Who else is applying?

What state do they live in?
Florida
New York
How old are they?
18 - 65
What site did they apply to?
Brooks Rehabilitation Hospital - University Campus
NYP Brooklyn Methodist Hospital Outpatient Rehabilitation
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I have Covid in January 2022. I felt like there was something wrong with my brain. I had a MRI in July/Aug and they found 2 strokes. I’m looking for ways to better my brain.
PatientReceived no prior treatments
~30 spots leftby Apr 2025